| Route | Ingredient | Form | Dose[b] | Brand names[c] | |
|---|---|---|---|---|---|
| Oral | Test. undecanoate | Capsule | 40 mg | Andriol, Jatenzo | |
| Sublingual | Testosterone | Tablet | 10 mg | Testoral | |
| Buccal | Testosterone | Tablet | 30 mg | Striant | |
| Intranasal | Testosterone | Nasal gel | 5.5 mg/spray, 120 sprays | Natesto | |
| Transdermal | Testosterone | Non-scrotal patch | 2.5, 4, 5, 6 mg/day | Androderm | |
| Non-scrotal patch | 150, 300 μg/day | Intrinsa | |||
| Scrotal patch[d] | 4, 6 mg/day | Testoderm | |||
| Topical gel | 25, 50, 75, 100, 125 mg/pump | AndroGel, Testim | |||
| Axillary solution | 30 mg/pump | Axiron | |||
| Rectal | Testosterone | Suppository | 40 mg | Rektandron | |
| Injection[e] | Test. enanthate | Oil solution | 50, 100, 180, 200, 250 mg/mL | Delatestryl | |
| Test. cypionate | Oil solution | 50, 100, 200, 250 mg/mL | Depo-Testosterone | ||
| Mixed test. esters[f] | Oil solution | 100, 250 mg/mL | Sustanon | ||
| Test. undecanoate | Oil solution | 750, 1000 mg | Aveed, Nebido | ||
| Implant | Testosterone | Pellet | 50, 75, 100, 200 mg | Testopel | |
Footnotes and sources:
| |||||
Template documentationSee also
- Testosterone (medication) § Available forms
- Pharmacokinetics of testosterone § Routes of administration
- Template:Available forms of estradiol
- Template:Available forms of progesterone
References
- ^ Nieschlag E (September 2006). "Testosterone treatment comes of age: new options for hypogonadal men". Clin. Endocrinol. (Oxf). 65 (3): 275–81. doi:10.1111/j.1365-2265.2006.02618.x. PMID 16918944.
- ^ Nieschlag E (January 2015). "Current topics in testosterone replacement of hypogonadal men". Best Pract. Res. Clin. Endocrinol. Metab. 29 (1): 77–90. doi:10.1016/j.beem.2014.09.008. PMID 25617174.
- ^ Byrne M, Nieschlag E (May 2003). "Testosterone replacement therapy in male hypogonadism". J. Endocrinol. Invest. 26 (5): 481–9. doi:10.1007/bf03345206. PMID 12906378.
- ^ Cappa M, Cianfarani S, Ghizzoni L, Loche S, Maghnie M (10 December 2015). Advanced Therapies in Pediatric Endocrinology and Diabetology: Workshop, Rome, October 2014. Karger Medical and Scientific Publishers. pp. 68–. ISBN 978-3-318-05637-2.
- ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Archived from the original on November 16, 2016. Retrieved November 16, 2016.
- ^ Melmed S (1 January 2016). Williams Textbook of Endocrinology. Elsevier Health Sciences. pp. 760–769. ISBN 978-0-323-29738-7.
- ^ Lenehan P (12 June 2003). Anabolic Steroids. CRC Press. pp. 108–109. ISBN 978-0-415-28029-7.
- ^ Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 1116, 1119, 1152, 1182–1185, 1195–1197, 2146. ISBN 978-0-7817-1750-2. Archived from the original on May 5, 2017.
- ^ Nieschlag E, Behre HM (6 December 2012). Testosterone: Action - Deficiency - Substitution. Springer Science & Business Media. pp. 1–, 9, 298, 309–331, 349–353, 366–367. ISBN 978-3-642-72185-4.
- ^ Krishna UR, Sheriar NR, Mandecklar A (1996). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.
- ^ Brotherton J (1976). Sex Hormone Pharmacology. Academic Press. pp. 18–19, 331, 336. ISBN 978-0-12-137250-7.
- ^ Wells BG, DiPiro JT, Schwinghammer TL, DiPiro CV (22 August 2014). Pharmacotherapy Handbook, 9/E. McGraw-Hill Education. p. 288. ISBN 978-0-07-182129-2.
- ^ Lauritzen C (1988). "Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien" [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles]. In Schneider HP, Lauritzen C, Nieschlag E (eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (in German). Walter de Gruyter. pp. 229–306. ISBN 978-3110109689. OCLC 35483492.
- ^ Apotekens informationsavdelning (1964). Apotekens synonymregister över farmacevtiska specialiteter. Apotekens informationsavdelning.
Rektandron FERRING supp. 40 mg • individ. dos. • 10 st.